scorecardresearch
Friday, March 29, 2024
Support Our Journalism
HomeHealthCovid-19 vaccine won't be available until January, Anthony Fauci says

Covid-19 vaccine won’t be available until January, Anthony Fauci says

There are five companies in the final stages of study for a coronavirus vaccine, with Pfizer and Moderna having fully enrolled their trials, US top infectious-disease doctor said.

Follow Us :
Text Size:

Washington: A vaccine to help control the coronavirus outbreak isn’t likely to be available in the U.S. until January, if then, according to Anthony Fauci, the nation’s top infectious-disease doctor.

President Donald Trump, pharmaceutical industry leaders and some public-health officials had said previously that an immunization to prevent Covid-19 could be available before the Nov. 3 election. That date has been consistently pushed back, however, as clinical studies — which are running at unprecedented speed — started to hit a few hurdles.

The trials are designed to run until a predetermined number of people who are enrolled get sick. The studies currently underway are unlikely to hit those benchmarks until sometime in December, Fauci said in an online interview with Howard Bauchner, the editor-in-chief of the Journal of the American Medical Association.

Once the data are available, the companies must analyze the findings, file with the U.S. Food and Drug Administration for emergency use and participate in an advisory committee hearing.

“Somewhere around December you will start to see companies with enough events” to have a data safety monitoring board look at the details, Fauci said. “Then it’s up to them to recommend that the company can then move forward. By moving forward, they can apply for an emergency use authorization from the FDA,” he said.

“Exactly when the EUA will be granted – could be January, could be later – we don’t know,” Fauci said.

There are five companies in the final stages of study for a coronavirus vaccine, with Pfizer Inc. and Moderna Inc. having fully enrolled their trials, Fauci said. At least one and maybe two of the companies will have enough safety data and perhaps even sufficient prolonged efficacy findings to apply for emergency use of their vaccines by December, he said.

Pfizer said Tuesday that the late-stage study of its experimental Covid-19 vaccine hadn’t yet reach the milestone number needed to determine if the shot is showing signs of benefit. The monitoring board of scientists overseeing the trial hasn’t conducted the first of four planned interim reviews because there haven’t yet been 32 cases of coronavirus infections among its 42,000 participants. –Bloomberg


Also read: 15-minute Covid test for just $5 to help end lab delays in the US


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular